Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment

BACKGROUND: Dedifferentiated chondrosarcomas (CS) are a high-grade variant of CS that confers a 5-year survival of around 10–24%. Dedifferentiated CS arising from the pelvis confers an even worse prognosis. QUESTIONS: (1) What is the prognosis of patients with dedifferentiated CS of the pelvis? (2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lex, Johnathan R., Evans, Scott, Stevenson, Jonathan D., Parry, Michael, Jeys, Lee M., Grimer, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293503/
https://www.ncbi.nlm.nih.gov/pubmed/30559960
http://dx.doi.org/10.1186/s13569-018-0110-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293503/
https://www.ncbi.nlm.nih.gov/pubmed/30559960
http://dx.doi.org/10.1186/s13569-018-0110-1

Ejemplares similares